Stay updated on Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial
Sign up to get notified when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.

Latest updates to the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive content changes were observed.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a unified Locations section listing all study sites by state (Alabama, Florida, Georgia, Louisiana, Michigan, North Carolina, Texas, Wisconsin), replacing the prior per-state location headings. This clarifies where the trial is conducted and helps users find recruitment sites.SummaryDifference0.9%

- Check48 days agoChange DetectedMinor metadata update: Revision v3.3.2 added and v3.3.1 removed, with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedThe Publications section text was updated to clarify that publications are automatically filled in from PubMed and may not be about the study, and the revision label changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe government funding operating-status notice has been removed from the page.SummaryDifference0.3%

- Check76 days agoChange DetectedNo substantive changes detected between the two screenshots. Core study information remains unchanged, with only cosmetic formatting or layout differences observed.SummaryDifference0.4%

Stay in the know with updates to Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.